Gemina Laboratories Ltd

NEW
FRA:8I7 (Canada)  
€ 0.018 (0%) Apr 9
At Loss
Market Cap:
€ 1.38M ($ 1.58M)
Enterprise V:
€ 1.53M ($ 1.75M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Name Current Vs Industry Vs History
Equity-to-Asset
-4.63
Debt-to-Equity
-0.05
Debt-to-EBITDA
-0.09
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-43.1
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
19.6
3-Year EPS without NRI Growth Rate
15.7
3-Year FCF Growth Rate
39.4
Name Current Vs Industry Vs History
5-Day RSI
41.18
9-Day RSI
41.07
14-Day RSI
38.18
3-1 Month Momentum %
-44.78
6-1 Month Momentum %
-93.1
12-1 Month Momentum %
-97.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.01
Quick Ratio
0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-10.5
Shareholder Yield %
26.09
Name Current Vs Industry Vs History
Operating Margin %
-25818.18
Net Margin %
-26636.36
EBITDA Margin %
-25318.18
FCF Margin %
-14.29
OCF Margin %
-14.29
ROA %
-229.48
ROIC %
-158.62
3-Year ROIIC %
34.99
ROC (Joel Greenblatt) %
-1808.38
Moat Score
2
Tariff Resilience Score
5

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-0.89
EV-to-EBITDA
-0.91
EV-to-Revenue
230.73
EV-to-FCF
2538
Earnings Yield (Greenblatt) %
-112.36
FCF Yield %
0.04

Financials

FRA:8I7's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Gemina Laboratories Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.007
EPS (TTM) (€) -0.025
Beta -
3-Year Sharpe Ratio -0.63
3-Year Sortino Ratio -0.9
Volatility % 62.33
14-Day RSI 38.18
14-Day ATR (€) 0.001649
20-Day SMA (€) 0.018225
12-1 Month Momentum % -97.09
52-Week Range (€) 0.017 - 0.715
Shares Outstanding (Mil) 76.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gemina Laboratories Ltd Filings

Filing Date Document Date Form
No Filing Data

Gemina Laboratories Ltd Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Gemina Laboratories Ltd Frequently Asked Questions

What is Gemina Laboratories Ltd(FRA:8I7)'s stock price today?
The current price of FRA:8I7 is €0.02. The 52 week high of FRA:8I7 is €0.72 and 52 week low is €0.02.
When is next earnings date of Gemina Laboratories Ltd(FRA:8I7)?
The next earnings date of Gemina Laboratories Ltd(FRA:8I7) is .
Does Gemina Laboratories Ltd(FRA:8I7) pay dividends? If so, how much?
Gemina Laboratories Ltd(FRA:8I7) does not pay dividend.

Articles on Gemina Laboratories Ltd

No articles.